標(biāo)題: Titlebook: Breast Cancer: Biological and Clinical Progress; Proceedings of the C L. Dogliotti,A. Sapino,G. Bussolati Conference proceedings 1992 Sprin [打印本頁(yè)] 作者: 代表 時(shí)間: 2025-3-21 18:46
書(shū)目名稱Breast Cancer: Biological and Clinical Progress影響因子(影響力)
書(shū)目名稱Breast Cancer: Biological and Clinical Progress影響因子(影響力)學(xué)科排名
書(shū)目名稱Breast Cancer: Biological and Clinical Progress網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Breast Cancer: Biological and Clinical Progress網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Breast Cancer: Biological and Clinical Progress被引頻次
書(shū)目名稱Breast Cancer: Biological and Clinical Progress被引頻次學(xué)科排名
書(shū)目名稱Breast Cancer: Biological and Clinical Progress年度引用
書(shū)目名稱Breast Cancer: Biological and Clinical Progress年度引用學(xué)科排名
書(shū)目名稱Breast Cancer: Biological and Clinical Progress讀者反饋
書(shū)目名稱Breast Cancer: Biological and Clinical Progress讀者反饋學(xué)科排名
作者: surrogate 時(shí)間: 2025-3-21 23:57 作者: 車床 時(shí)間: 2025-3-22 02:54 作者: 吹牛需要藝術(shù) 時(shí)間: 2025-3-22 05:31 作者: Digest 時(shí)間: 2025-3-22 09:32 作者: Minutes 時(shí)間: 2025-3-22 13:21
https://doi.org/10.1007/978-3-7091-5637-7disease. Recent studies have suggested the involvement of certain oncogenes and oncosuppressor genes in the development of this disease. Ras oncogenes in particular are activated in a high proportion of breast tumors and increased levels of ras protein correlates with poor prognosis. Ras signals may作者: sorbitol 時(shí)間: 2025-3-22 20:20
Michael S. Kilberg,Dieter H?ussinger in many human cancers. The . gene was found to be overexpressed in squamous carcinomas (1 – 3), in renal cell carcinomas (4) and in glioblastomas (5 – 6); the . gene in carcinomas of the breast (7), ovary (8), stomach (9), colon (10) and salivary glands (10). In most cases . gene overexpression has作者: 考博 時(shí)間: 2025-3-22 22:07 作者: Fecal-Impaction 時(shí)間: 2025-3-23 02:23
Vittorio Sgaramella,Sandro Eridaniudies have now appeared describing the use of different transgenes and several different promotor systems to produce mammary tumors (.,.). The use of binary systems for tissue-specific promotion of oncogenes and the production of bigenic and trigenic animals through hybrid crosses promise to expand 作者: dysphagia 時(shí)間: 2025-3-23 06:44
Eric D. Marsh,Amy R. Brooks-Kayale growth factors such as epidermal growth factor (EGF), transforming growth factor alpha (TGF-a), insulin-like growth factors (IGF-I and IGF-II), fibroblast growth factors (FGF) [1], and possibly platelet derived growth factor (PDGF) [2]. The other is the negative pathway involving agents such as me作者: 臥虎藏龍 時(shí)間: 2025-3-23 12:53
Hugo F. Carrer,María J. Cambiassoetiology of the disease as a promoter for the growth of initiated cells and as a promotor for growth of the established tumor cells. A prerequisite for estrogen stimulated cell proliferation is presence of estrogen receptors in the tumor cells, and about 60% of the primary breast tumors contain estr作者: Nutrient 時(shí)間: 2025-3-23 15:10
https://doi.org/10.1007/978-1-60761-287-2uman breast cancer cell line in response to lactogenic peptide hormones (human prolactin and human growth hormone) and androgen, and independently by Haagensen and co-workers (3) as a protein found in abundance in the fluid of gross cystic disease of the breast. Haagensen and colleagues (3, 4) have 作者: STALL 時(shí)間: 2025-3-23 18:16
Annie-Claude Roche,Michel Monsigny with their three variants, c-Ha-ras, v-Ha-ras and n-Ha-ras, has been widely studied and reported to be involved in mammary carcinomas induced in experimental animals by chemical carcinogens, in breast cancer cell lines, in primary breast cancers, as rare alleles or as an amplification or expression作者: 小口啜飲 時(shí)間: 2025-3-24 02:07 作者: 讓空氣進(jìn)入 時(shí)間: 2025-3-24 05:37 作者: 雜役 時(shí)間: 2025-3-24 10:07 作者: 欄桿 時(shí)間: 2025-3-24 13:29 作者: 代理人 時(shí)間: 2025-3-24 17:40 作者: 大笑 時(shí)間: 2025-3-24 22:10 作者: 串通 時(shí)間: 2025-3-25 03:01 作者: 別名 時(shí)間: 2025-3-25 04:46
Interactions Between Malignant and Non-Malignant Components of the Breastpresent merely 5% of the organ in senility (Figure 1). In contrast, other components such as stroma and adipose tissue form the bulk of the breast although their proportions vary markedly at different stages of development. These elements are not inert and the potential exists for inter-communication between the various compartments of the breast.作者: Cuisine 時(shí)間: 2025-3-25 09:16 作者: CLOT 時(shí)間: 2025-3-25 12:18
oratory and clinical research findings. Of major importance are therefore meetings promoting fast transfer to clinical applications of findings by basic scientists. The present volume, reporting the proceedings of the 1991 Biennial Conference of the International Association for Breast Cancer Resear作者: 令人心醉 時(shí)間: 2025-3-25 19:44
Michael S. Kilberg,Dieter H?ussinger– 6); the . gene in carcinomas of the breast (7), ovary (8), stomach (9), colon (10) and salivary glands (10). In most cases . gene overexpression has been associated with poor prognosis (7,11–12). . and ., both encoding tyrosine kinase receptors, were found to be amplified in breast cancers (13).作者: 仔細(xì)檢查 時(shí)間: 2025-3-25 22:25
Annie-Claude Roche,Michel Monsignyrimental animals by chemical carcinogens, in breast cancer cell lines, in primary breast cancers, as rare alleles or as an amplification or expression of the gene product of the ras gene, the p21 protein (3 – 6). However, whether the ras oncogene is a causative agent of breast cancer has not been proven as yet.作者: 多骨 時(shí)間: 2025-3-26 04:07
Expression of the , Oncogene in Human Tumors– 6); the . gene in carcinomas of the breast (7), ovary (8), stomach (9), colon (10) and salivary glands (10). In most cases . gene overexpression has been associated with poor prognosis (7,11–12). . and ., both encoding tyrosine kinase receptors, were found to be amplified in breast cancers (13).作者: 罐里有戒指 時(shí)間: 2025-3-26 05:42 作者: Coma704 時(shí)間: 2025-3-26 11:27 作者: 膽汁 時(shí)間: 2025-3-26 14:03
Vittorio Sgaramella,Sandro Eridaniese animals and there have been no comparative studies of the effects of different oncogenes on the morphogenesis of the mammary gland. In the following review, we will summarize our collective experience with mammary growth and development and with mammary tumorigenesis in one set of transgenic animals.作者: Sigmoidoscopy 時(shí)間: 2025-3-26 18:20
Mammary Morphogenesis and Oncogenesese animals and there have been no comparative studies of the effects of different oncogenes on the morphogenesis of the mammary gland. In the following review, we will summarize our collective experience with mammary growth and development and with mammary tumorigenesis in one set of transgenic animals.作者: disciplined 時(shí)間: 2025-3-26 21:51 作者: bleach 時(shí)間: 2025-3-27 04:12 作者: CHOKE 時(shí)間: 2025-3-27 06:11 作者: Stricture 時(shí)間: 2025-3-27 12:46 作者: ACTIN 時(shí)間: 2025-3-27 15:08
c-,B-2, a Tyrosine Kinase Growth Factor Receptor and its Role in Breast Cancerligand binding domain. The group is subdivided into four subgroups based on differences in predicted structure (1). The type I subgroup includes the epidermal growth factor receptor (EGFR), encoded by the . gene, . and ., which have two cysteine rich domains within the extracellular region and a sin作者: wangle 時(shí)間: 2025-3-27 21:01
Mammary Morphogenesis and Oncogenesudies have now appeared describing the use of different transgenes and several different promotor systems to produce mammary tumors (.,.). The use of binary systems for tissue-specific promotion of oncogenes and the production of bigenic and trigenic animals through hybrid crosses promise to expand 作者: 樣式 時(shí)間: 2025-3-27 21:55
Interdependence of Hormones and Growth Factors in Lobulo-Alveolar Development of the Mammary Gland ae growth factors such as epidermal growth factor (EGF), transforming growth factor alpha (TGF-a), insulin-like growth factors (IGF-I and IGF-II), fibroblast growth factors (FGF) [1], and possibly platelet derived growth factor (PDGF) [2]. The other is the negative pathway involving agents such as me作者: 不可磨滅 時(shí)間: 2025-3-28 03:45
The Role of Estrogen Regulated Secreted Proteins for Growth Regulation of Human Breast Canceretiology of the disease as a promoter for the growth of initiated cells and as a promotor for growth of the established tumor cells. A prerequisite for estrogen stimulated cell proliferation is presence of estrogen receptors in the tumor cells, and about 60% of the primary breast tumors contain estr作者: 腫塊 時(shí)間: 2025-3-28 06:57
The Prolactin-Inducible Protein / Gross Cystic Disease Fluid Protein (PIP/GCDFP-15): Genetic Analysiuman breast cancer cell line in response to lactogenic peptide hormones (human prolactin and human growth hormone) and androgen, and independently by Haagensen and co-workers (3) as a protein found in abundance in the fluid of gross cystic disease of the breast. Haagensen and colleagues (3, 4) have 作者: 提名的名單 時(shí)間: 2025-3-28 13:05 作者: 先鋒派 時(shí)間: 2025-3-28 16:31
Interactions Between Malignant and Non-Malignant Components of the Breastrelationship between normal and malignant epithelium and the processes which may destabilize normal epithelium and lead to carcinogenesis. However, it is important to realise that the breast is a complex organ in which, apart from during pregnancy and lactation, parenchymal elements constitute only 作者: 發(fā)展 時(shí)間: 2025-3-28 20:48
Involvement of Heparanase and Extracellular Matrix-Bound Fibroblast Growth Factor in Tumor Progressielial cells (EC) and was identified in epithelial and endothelial basement membranes of the rat fetus, bovine cornea and human blood vessels. Despite the ubiquitous presence of bFGF in normal tissues, EC proliferation in these tissues is usually very low with turnover time measured in years. This ra作者: LVAD360 時(shí)間: 2025-3-29 00:41 作者: 搖擺 時(shí)間: 2025-3-29 06:18
Benign Breast Disease: Links to Risk of Cancerthreat to life. However, the term “disease” should include some element of discomfort or indicate an association with threat to life (malignancy). Thus, the term . should not be applied to trivial changes present in the majority of the population, which do not have a negative impact on the quality o作者: Inveterate 時(shí)間: 2025-3-29 10:51 作者: Melanoma 時(shí)間: 2025-3-29 15:00
c-,B-2, a Tyrosine Kinase Growth Factor Receptor and its Role in Breast Cancerthe tyrosine kinase region is divided by a kinase insert. Subgroup IV, which includes the fibroblast growth factor receptors, is essentially very similar to subgroup III but the extracellular domain has only three immunoglobulinlike structures. The kinase insert of group III and IV contains a tyrosi作者: N斯巴達(dá)人 時(shí)間: 2025-3-29 17:13 作者: EPT 時(shí)間: 2025-3-29 21:38 作者: 可忽略 時(shí)間: 2025-3-30 00:37 作者: Control-Group 時(shí)間: 2025-3-30 07:12 作者: 搖曳 時(shí)間: 2025-3-30 11:07
Estrogen and Progesterone Receptor Activity in Breast Cancer Cellsved understanding of the function and regulation of expression of these transcription factors is emerging from studies of the structure, composition and dynamics of the receptor proteins and the genes that encode them. The cloning and molecular analysis of all of the known steroid receptors has led 作者: instructive 時(shí)間: 2025-3-30 13:29 作者: BUCK 時(shí)間: 2025-3-30 17:32
Conference proceedings 1992es and to the identification of risk factors, a way to select populations at higher risk and, possibly, to help in preventing the disease. Special emphasis is given to the establishment of diagnostic criteria and to the selection of prognostic factors, which must support an effective therapeutic pla作者: 譏笑 時(shí)間: 2025-3-30 22:51 作者: languid 時(shí)間: 2025-3-31 03:34 作者: Inertia 時(shí)間: 2025-3-31 05:23 作者: 熄滅 時(shí)間: 2025-3-31 13:11 作者: 柏樹(shù) 時(shí)間: 2025-3-31 15:05
https://doi.org/10.1007/978-1-60761-287-2l laboratories are using the GCDFP-15/PIP as a marker for abnormal breast functions and have observed, for instance, that the contents of GCDFP-15 in gross cystic disease fluid is correlated with that of androgens, prolactin and epidermal growth factor (5). PIP/GCDFP-15 protein is abundant in gross
